Frank Mottola, Chief Officer of Supernus Pharmaceuticals SUPN, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $1.1M. The latest trade was on 03/09.

FM

FM

Frank Mottola

SVP, Chief Tech. Ops. Officer

Company

Supernus Pharmaceuticals SUPN

First filing

23/01/17

Trades

88 trades

Buys / sales

0 / 8

12-month net buying

−$1.1M

Last trade

03/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Supernus PharmaceuticalsSUPN	Open-market sale	03/09	03/10	1,623 sh	$53.65	$87,073.95	−8.1%
Supernus PharmaceuticalsSUPN	Open-market sale10b5-1 plan	25/12/19	25/12/22	20,000 sh2 trades	$50.41avg.	$1,008,150	−56.3%
Supernus PharmaceuticalsSUPN	Open-market sale	25/09/12	25/09/15	5,000 sh	$45.87	$229,350	−24.4%
Supernus PharmaceuticalsSUPN	Open-market sale	25/08/25	25/08/27	14,000 sh	$44.51	$623,140	−47.5%
Supernus PharmaceuticalsSUPN	Open-market sale	24/11/07	24/11/08	15,000 sh	$36.98	$554,700	−64.7%
Supernus PharmaceuticalsSUPN	Open-market sale	23/11/14	23/11/16	1,110 sh	$28.13	$31,224.3	−16.3%
Supernus PharmaceuticalsSUPN	Open-market sale	23/03/14	23/03/16	4,780 sh	$35.99	$172,032.2	−50.2%